SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder...
https://pubmed.ncbi.nlm.nih.gov/32142651/Actively Recruiting
Led by York University · Updated on 2026-06-05
30
Participants Needed
1
Research Sites
26 weeks
Total Duration
This research aims to evaluate whether 12 weeks of taurine supplementation can improve vascular function and cardiovascular responses to upright posture in people with Long COVID. Long COVID is defined as new or continuing symptoms lasting at least two months, starting three months after COVID-19 infection, and it is linked to vascular dysfunction and taurine deficiency. The study will focus on measuring vascular health and orthostatic tolerance, which relates to symptoms like lightheadedness when standing. Participants will either be taking taurine supplements for 12 weeks or not taking them, forming two groups for comparison. Vascular function will be assessed using devices like EndoPAT and Duplex ultrasound, while orthostatic responses will be measured during a 5-minute head-up tilt test. Heart rate variability will be recorded both in the lab and at home weekly using a heart rate monitor. The study involves two visits at baseline and after 12 weeks, with at-home monitoring in between. During the study, participants will undergo detailed assessments including blood flow, heart rate, blood pressure, and brain blood flow measurements. Questionnaires will track symptoms and autonomic function. Researchers will analyze changes before and after 12 weeks to understand the effects of taurine supplementation. The total participation time includes two one-hour lab visits and weekly home data collection over 12 weeks.
CONDITIONS
Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?
H
Heather Edgell, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
York University
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants are observed to compare those who are taking 12 weeks of taurine supplementation with those who are not taking taurine.
2 visits (baseline and after 12 weeks, in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder...
https://pubmed.ncbi.nlm.nih.gov/32142651/Stephen M Ratchford, Jonathon L Stickford, Valesha M Province...
https://pubmed.ncbi.nlm.nih.gov/33306450/Aranka V Ballering, Sander K R van Zon, Tim C Olde Hartman...
https://pubmed.ncbi.nlm.nih.gov/35934007/Dick H J Thijssen, Mark A Black, Kyra E Pyke...
https://pubmed.ncbi.nlm.nih.gov/20952670/Qianqian Sun, Bin Wang, Yingsha Li...
https://pubmed.ncbi.nlm.nih.gov/26781281/Mobin Khoramjoo, Kaiming Wang, Karthik Srinivasan...
https://pubmed.ncbi.nlm.nih.gov/38837993/Zsuzsanna Varga, Andreas J Flammer, Peter Steiger...
https://pubmed.ncbi.nlm.nih.gov/32325026/Mary C Corretti, Todd J Anderson, Emelia J Benjamin...
https://pubmed.ncbi.nlm.nih.gov/11788217/J Wittes, E Brittain
https://pubmed.ncbi.nlm.nih.gov/2345839/York University
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor